Search

Search Bar
08/04/2023 Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition
Diaz, M, Mestres-Arenas, A, Lerin, C, Cereijo, R, Lopez-Bermejo, A, de Zegher, F, Villarroya, F, Ibanez, L. Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition. PEDIATRIC RESEARCH. 2023; 94(3)DOI:10.1038/s41390-023-02595-1. PMID:37031297. IF:3.100(Q1/2D).
29/03/2023 Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort
Palacio-Vieira J., Moreno-Fornés S., Díaz Y., Aceitón J., Bruguera A., Nomah D.K., Llibre J.M., Knobel H., Chivite I., Miro J.M., Domingo P., Suanzes P., Fanjul F., Navarro G., Macorigh L., Mera A., Casabona J., Imaz A., Reyes-Urueña J.. Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort. HIV MEDICINE. 2023; 24(9)DOI:10.1111/hiv.13486. PMID:36990962. IF:2.800(Q2/5D).
02/03/2023 Meteorin-like levels are associated with active brown adipose tissue in early infancy
Garcia-Beltran, C, Navarro-Gascon, A, Lopez-Bermejo, A, Quesada-Lopez, T, de Zegher, F, Ibanez, L, Villarroya, F. Meteorin-like levels are associated with active brown adipose tissue in early infancy. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1136245. PMID:36936161. IF:3.900(Q2/3D).
01/03/2023 Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Waters, L, Assoumou, L, Gonzalez-Cordon, A, Rusconi, S, Domingo, P, Gompels, M, de Wit, S, Raffi, F, Stephan, C, Masia, M, Rockstroh, J, Katlama, C, Behrens, GMN, Moyle, G, Johnson, M, Fox, J, Stellbrink, HJ, Guaraldi, G, Florence, E, Esser, S, Gatell, JM, Pozniak, A, Martinez, E. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial. CLINICAL INFECTIOUS DISEASES. 2023; 76(5)DOI:10.1093/cid/ciac827. PMID:36259527. IF:8.200(Q1/1D).
01/01/2023 Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain following First-Line Antiretroviral Therapy
Berenguer J., Jarrín I., Bellón J.M., Díez C., Jiménez-Sousa M.A., Roca C., González-García J., Dalmau D., Olalla J., Herrero C., Villarroya F., Domingo P., Resino S.. Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain following First-Line Antiretroviral Therapy. CLINICAL INFECTIOUS DISEASES. 2023; 76(6)DOI:10.1093/cid/ciac880. PMID:36345912. IF:(Q/D).
01/01/2023 Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study
Martín-Iguacel R., Vazquez-Friol M.C., Burgos J., Bruguera A., Reyes-Urueña J., Moreno-Fornés S., Aceitón J., Díaz Y., Domingo P., Saumoy M., Knobel H., Dalmau D., Borjabad B., Johansen I.S., Miro J.M., Casabona J., Llibre J.M.. Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study. Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1182359. PMID:37415770. IF:3.100(Q1/2D).